Jim Datin is Highlighted in TBJ Talking About BioAgilytix’ Performance in 2020 and Beyond

In this news article, our CEO Jim Datin discusses with Triangle Business Journal about BioAgilytix’ performance and the challenges they have experienced in 2020.

Featured Expert

Pharmacokinetics & Pharmacodynamics​

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.
220328 Adleverage_Scientific Icon Illustrations_#46-65_CO_Per FIles